Identification of novel epilepsy-associated exonic (螖2–3 and 螖5–9) GPHN deletions
螖5–9 GPHN impairs oligomerization and clustering of gephyrin at GABAergic synapses.
螖2–3 GPHN leads to a premature stop-codon after exon 1.
Clinically, intra-cortical inhibition was reduced in the 螖5–9 GPHN patient.
GPHN deletions represent a rare genetic risk factor for IGE.